REQUEST A DEMO
Total
USD $0.00
Search more companies

Fresenius Kabi Horatev CZ s.r.o. (Czech Republic)

Main Activities: Medical Equipment and Supplies Manufacturing
Full name: Fresenius Kabi Horatev CZ s.r.o. Profile Updated: September 30, 2021
Buy our report for this company USD 29.95 Most recent financial data: 2019 Available in: English Download a sample report

Fresenius HemoCare CZ s.r.o has been active on the Czech market without interruption since 1992. Since its establishment, it has set as its priority not only the sale of haemodialysis devices, dialysers and other transfusion equipment; an integral part of its over is comprehensive maintenance of all the sold goods. The main buyers of goods and services are hospitals,

Headquarters
Horatev 104
Nymburk; Stredocesky; Postal Code: 28913

Contact Details: Purchase the Fresenius Kabi Horatev CZ s.r.o. report to view the information.

Basic Information
Total Employees:
Purchase the Fresenius Kabi Horatev CZ s.r.o. report to view the information.
Outstanding Shares:
Purchase the Fresenius Kabi Horatev CZ s.r.o. report to view the information.
Registered Capital:
Purchase the Fresenius Kabi Horatev CZ s.r.o. report to view the information.
Ratings:
Purchase the Fresenius Kabi Horatev CZ s.r.o. report to view the information.
Incorporation Date:
April 21, 2005
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Company Performance
Financial values in the chart are available after Fresenius Kabi Horatev CZ s.r.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-2.7%
Total operating revenue
-0.15%
Operating profit (EBIT)
-51.22%
EBITDA
-20.99%
Net Profit (Loss) for the Period
-76.65%
Total assets
-3.08%
Total equity
1.6%
Operating Profit Margin (ROS)
-2.41%
Net Profit Margin
-2.17%
Return on Equity (ROE)
-5.29%
Quick Ratio
0.1%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?